Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-230505
Filing Date
2025-10-03
Accepted
2025-10-03 17:36:27
Documents
1
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3913
  Complete submission text file 0001193125-25-230505.txt   5378
Mailing Address BAARERSTRASSE 14 ZUG Switzerland
Business Address BAARERSTRASSE 14 ZUG Switzerland 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CRISPR THERAPEUTICS, INC. 105 W FIRST STREET BOSTON MA 02127
Business Address
Prasad Raju (Reporting) CIK: 0001968317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 251375135